parthenolide has been researched along with Dermatitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liebel, F; Lyte, P; Martin, K; Shapiro, S; Southall, M; Sur, R | 1 |
Asahina, A; Kagami, S; Kakinuma, T; Komine, M; Nakamura, K; Saeki, H; Sasaki, K; Tamaki, K; Tsunemi, Y | 1 |
1 trial(s) available for parthenolide and Dermatitis
Article | Year |
---|---|
Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Topics: Adult; Animals; Anti-Inflammatory Agents; Cells, Cultured; Dermatitis; Erythema; Female; Humans; Inflammation; Inflammation Mediators; Keratinocytes; Leukocytes, Mononuclear; Macrophages; Male; Mice; Middle Aged; Plant Extracts; Sesquiterpenes; Tanacetum parthenium; Young Adult | 2009 |
1 other study(ies) available for parthenolide and Dermatitis
Article | Year |
---|---|
CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27.
Topics: Cell Line; Chemokine CCL27; Chemokines; Chemokines, CC; Dermatitis; Humans; Imidazoles; Interleukin-1; Keratinocytes; Ligands; MAP Kinase Signaling System; NF-kappa B; Pyridines; Receptors, CCR10; Receptors, Chemokine; Sesquiterpenes; Signal Transduction; Tumor Necrosis Factor-alpha | 2006 |